6322-57-2

Usage

Uses

Used in Pharmaceutical Development:
AKOS B018318 is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure and properties may contribute to the development of new drugs with improved efficacy and safety profiles.
Used in Agrochemical Research:
In the agrochemical industry, AKOS B018318 is used as a research compound to explore its potential as a component in the development of new pesticides, herbicides, or other crop protection agents. Its unique properties may offer novel solutions to agricultural challenges.
Used in Advanced Material Synthesis:
AKOS B018318 is utilized as a building block in the synthesis of advanced materials with specific properties, such as high thermal stability, chemical resistance, or unique electronic characteristics. Its incorporation into these materials may lead to innovative applications in various industries.
Used in Research and Development:
AKOS B018318 serves as a valuable research tool in various scientific fields, including organic chemistry, materials science, and biochemistry. Its unique properties and structure provide researchers with opportunities to explore new reactions, mechanisms, and applications, further expanding the understanding of chemical processes and material properties.

InChI:InChI=1/C12H11NO3S2/c1-2-16-9-5-7(3-4-8(9)14)6-10-11(15)13-12(17)18-10/h3-6,14H,2H2,1H3,(H,13,15,17)/b10-6+

Upstream product

• 121-32-4 4-hydroxy-3-ethoxybenzaldehyde 
• 141-84-4 2-thioxo-4-thiazolidinone 

Relevant academic research and scientific papers

Dynamic multicolor protein labeling in living cells

Yellow Fluorescence-Activating and absorption-Shifting Tag (Y-FAST, hereafter called FAST) is a 14 kDa protein tag giving a bright green-yellow fluorescent complex upon interaction with the fluorogenic dye 4-hydroxy-3-methylbenzylidene rhodanine (HMBR). H

New compounds having skin whitening, antioxidant and PPAR activity, and medical use thereof

PURPOSE: A novel compound with skin whitening, antioxidation, and PPAR activation effects, and a medical use thereof are provided to be used for a pharmaceutical composition or a cosmetic product. CONSTITUTION: A compound is denoted by chemical formula 1. A skin whitening composition contains the compound as an active ingredient. An antioxidative composition for preventing or treating oxidative diseases contains the compound of chemical formula 1 as an active ingredient. The oxidative diseases are selected among skin aging, pigmentation, wrinkling, psoriasis, or eczema. The composition prevents or treats diseases which are regulated by PPAR(peroxisome proliferator-activated receptor) activity. The PPAR includes PPAR alpha or PPAR gamma.

NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR

Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPARα and PPARγ activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.

Method for treating multiple sclerosis

Provided is a method of treating multiple sclerosis employing certain aryl-substituted rhodanines.

COMPOUNDS USEFUL AS HYPOGLYCEMIC AGENTS AND FOR TREATING ALZHEIMER'S DISEASE

Provided are methods for treating hyperglycemia and Alzheimer's disease utilizing certain rhodanine derivatives. Certain of the rhodanine derivatives utilized in the instant methods are novel and, accordingly, such compounds and pharmaceutical formulation